The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-(2-(piperidin-1-yl)ethoxy)benzoyl)-2-(4-(4-(trifluoromethyl)phenylsulfonyloxy)phenyl)benzo[b]thiophen-6-yl 4-(trifluoromethyl)benzenesulfonate ID: ALA4540180
PubChem CID: 155549933
Max Phase: Preclinical
Molecular Formula: C42H33F6NO8S3
Molecular Weight: 889.91
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(OS(=O)(=O)c3ccc(C(F)(F)F)cc3)cc2)sc2cc(OS(=O)(=O)c3ccc(C(F)(F)F)cc3)ccc12
Standard InChI: InChI=1S/C42H33F6NO8S3/c43-41(44,45)29-8-17-34(18-9-29)59(51,52)56-32-14-6-28(7-15-32)40-38(39(50)27-4-12-31(13-5-27)55-25-24-49-22-2-1-3-23-49)36-21-16-33(26-37(36)58-40)57-60(53,54)35-19-10-30(11-20-35)42(46,47)48/h4-21,26H,1-3,22-25H2
Standard InChI Key: WNWQJMPMZHOSSV-UHFFFAOYSA-N
Molfile:
RDKit 2D
60 66 0 0 0 0 0 0 0 0999 V2000
22.2664 -11.7502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9763 -12.1588 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.9752 -11.3397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3232 -10.4914 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9187 -11.2013 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.7357 -11.1966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8202 -13.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2989 -12.8522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8243 -12.1836 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.0442 -12.4353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0401 -13.2525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8078 -14.3339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1202 -12.8522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3344 -12.0185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3344 -13.6611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5094 -14.7425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7398 -15.6174 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0896 -14.7301 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5247 -12.1464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5123 -13.5621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4970 -15.5597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2234 -14.3380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6286 -12.4312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6286 -13.2525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7505 -12.8687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9127 -15.5803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3460 -12.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3336 -13.5745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9250 -14.7590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1945 -15.9765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6143 -15.9971 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.0299 -16.0136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9187 -12.0185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5677 -12.8687 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.3283 -15.5927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4414 -16.0425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7522 -14.8002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4621 -14.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1555 -15.6381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1637 -14.8168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2147 -10.7906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7935 -12.1610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2229 -9.9765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5198 -9.5658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8111 -9.9702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8100 -10.7894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5137 -11.1964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1972 -12.8702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0137 -12.8727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4250 -12.1656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0139 -11.4544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1988 -11.4554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1047 -9.5593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1073 -8.7421 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.2422 -12.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6498 -12.8749 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.6517 -11.4595 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.3957 -9.9656 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.3941 -9.1501 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.0581 -12.1629 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 2 0
6 5 2 0
8 7 2 0
9 8 1 0
10 11 1 0
11 7 1 0
12 7 1 0
13 8 1 0
14 10 2 0
15 11 2 0
16 12 1 0
17 32 1 0
18 12 2 0
19 13 2 0
20 13 1 0
21 16 1 0
22 16 2 0
23 24 2 0
24 15 1 0
25 28 1 0
26 29 2 0
27 19 1 0
28 20 2 0
29 22 1 0
30 21 2 0
31 26 1 0
32 35 1 0
33 23 1 0
34 25 1 0
35 31 1 0
36 17 1 0
37 17 1 0
38 37 1 0
39 36 1 0
40 38 1 0
10 9 1 0
30 26 1 0
14 23 1 0
27 25 2 0
39 40 1 0
33 5 1 0
5 41 1 0
34 2 1 0
2 42 1 0
41 43 2 0
43 44 1 0
44 45 2 0
45 46 1 0
46 47 2 0
47 41 1 0
42 48 2 0
48 49 1 0
49 50 2 0
50 51 1 0
51 52 2 0
52 42 1 0
45 53 1 0
53 54 1 0
50 55 1 0
55 56 1 0
55 57 1 0
53 58 1 0
53 59 1 0
55 60 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 889.91Molecular Weight (Monoisotopic): 889.1272AlogP: 10.24#Rotatable Bonds: 13Polar Surface Area: 116.28Molecular Species: NEUTRALHBA: 10HBD: ┄#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 8.01CX LogP: 10.85CX LogD: 10.15Aromatic Rings: 6Heavy Atoms: 60QED Weighted: 0.06Np Likeness Score: -0.77
References 1. El-Gamal MI, Ullah S, Zaraei SO, Jalil S, Zaib S, Zaher DM, Omar HA, Anbar HS, Pelletier J, Sévigny J, Iqbal J.. (2019) Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase., 181 [PMID:31382118 ] [10.1016/j.ejmech.2019.07.063 ] 2. Nadel, Yael Y and 11 more authors. 2014-06-12 Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold. [PMID:24846781 ] 3. Lee, Sang-Yong SY and 5 more authors. 2016-07-15 Thiazolo[3,2-a]benzimidazol-3(2H)-one derivatives: Structure-activity relationships of selective nucleotide pyrophosphatase/phosphodiesterase1 (NPP1) inhibitors. [PMID:27265686 ] 4. Zelikman, Vadim V and 8 more authors. 2018-05-10 Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-Pα,α-Dithiophosphate Analogues. [PMID:29681152 ] 5. Nassir, Molhm and 8 more authors. 2019-12-15 Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold. [PMID:31610377 ] 6. Ahmad, Haseen and 7 more authors. 2020-12-15 Synthesis of biphenyl oxazole derivatives via Suzuki coupling and biological evaluations as nucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors. [PMID:32883636 ]